News from multicell technologies, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 20, 2014, 08:39 ET

MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has filed additional U.S. and international patent applications covering MCT-485 and its...

Jan 15, 2014, 08:39 ET

MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a U.S. provisional patent application concerning composition of matter,...

Nov 13, 2013, 08:13 ET

MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a second U.S. patent application concerning methods and formulations to...

Oct 02, 2013, 08:00 ET

MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the signing of a new sponsored research agreement with Anand...

Aug 06, 2013, 08:00 ET

MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and Genisphere LLC will collaborate on the development of targeted MCT-485...

May 16, 2013, 08:00 ET

MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) is pleased to announce the filing of a U.S. patent application concerning methods and...

Dec 26, 2012, 08:00 ET

MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) presented at the 2012 American Society for Cell Biology® (ASCB®) Annual...

Oct 22, 2012, 17:30 ET

Grant G. Miller Joins Board of MultiCell Technologies

MultiCell Technologies, Inc. (MCET.OB), a clinical-stage biopharmaceutical company, has added Grant G. Miller to its board of directors. Mr. Miller...

Sep 27, 2012, 08:00 ET

MultiCell Technologies To Announce Positive Preclinical Results at 2012 ASCB Meeting

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the acceptance by the American Society for Cell...

Sep 06, 2012, 13:49 ET

Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies

 MultiCell Technologies, Inc. (MCET.OB), a clinical-stage biopharmaceutical company, has added Scott Lukeman, Ph.D., to its board of...

Aug 14, 2012, 12:35 ET

MultiCell Announces Results of Shareholders' Meeting

 MultiCell Technologies, Inc. (OTCBB: MCET.OB), a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools...

Aug 10, 2012, 08:00 ET

MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the updated preclinical research results for MCT-465 and...

May 16, 2012, 08:00 ET

MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce representatives from the Company will present preclinical...

Feb 16, 2012, 08:30 ET

Xenogenics Received Rights to Polyanhydride Compounds Drug Delivery Patent

 Xenogenics Corporation, a subsidiary of MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has exclusive license rights to a...

Jan 03, 2012, 08:30 ET

MultiCell Technologies Receives Final Payment Under QTDP Program

 MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has received the final cash grant award payment of $303,102 under the U.S....

Jul 11, 2011, 08:30 ET

MultiCell and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) ("MultiCell") today announced that it entered into a sponsored research agreement with...

May 31, 2011, 08:30 ET

MultiCell Technologies is Granted Stem Cell Patent

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent...

Nov 02, 2010, 08:00 ET

MultiCell Technologies Receives $733,437 Cash Grant Award Under U.S. Government's Qualifying Therapeutic Discovery Project Program

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) announces it has received cash grant awards under the U.S. government's Qualifying...

Oct 19, 2010, 08:00 ET

MultiCell's Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the...

Aug 02, 2010, 08:00 ET

MultiCell Technologies Applies for Qualifying Therapeutic Discovery Project Grants

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announces it has submitted four separate grant applications under the U.S. government's...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge